Company profile for Hutchmed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capability. As of 2020, we have an in-house scientific team of over 600 professionals, and a pipeline of 10 clinical stage drug candidates in clinical studies around the world. We have also developed a profitable commercial plat...
We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capability. As of 2020, we have an in-house scientific team of over 600 professionals, and a pipeline of 10 clinical stage drug candidates in clinical studies around the world. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes prescription drugs and consumer health products, as well as two of our marketed novel oncology products.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Hong Kong
Address
Address
48th Floor, Cheung Kong Center 2 Queen's Road Central
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/08/3201158/0/en/HUTCHMED-Announces-Expanded-Coverage-on-National-Reimbursement-Drug-List-and-Inclusion-in-the-First-Commercial-Insurance-Drug-List-in-China.html

GLOBENEWSWIRE
07 Dec 2025

https://www.globenewswire.com/news-release/2025/11/27/3195434/0/en/HUTCHMED-Highlights-Clinical-Data-to-be-Presented-at-the-2025-ESMO-Asia-Congress-and-the-2025-ASH-Annual-Meeting.html

GLOBENEWSWIRE
26 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181024/0/en/HUTCHMED-Announces-Enrollment-Completed-of-SAFFRON-Global-Phase-III-Trial-of-ORPATHYS-and-TAGRISSO-Combination-for-Certain-Lung-Cancer-Patients-with-MET-Overexpression-and-or-Ampli.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3178821/0/en/HUTCHMED-Highlights-Pipeline-and-Business-Progress-at-R-D-Updates-Event.html

GLOBENEWSWIRE
02 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-23/hutchmed-highlights-hmpl-a251-data-presented-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics

PHARMIWEB
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3171612/0/en/HUTCHMED-Highlights-HMPL-A251-Data-Presented-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics.html

GLOBENEWSWIRE
22 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty